Diagnosis and treatment of levothyroxine pseudomalabsorption

Netherlands Journal of Medicine

Volumn 62, Issue 4, 2004, Pages 114-118

  Lips, D J ^a   van Reisen, M T ^a   Voigt, V ^a   Venekamp, W ^a  

^a Zuyderland Medical Centre   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; ALUMINUM HYDROXIDE; AMIODARONE; ANION EXCHANGE RESIN; CALCIUM CARBONATE; CARBAMAZEPINE; COLESTIPOL; COLESTYRAMINE; ESTROGEN; FERROUS SULFATE; IODINE 131; LAXATIVE; LEVOTHYROXINE; MEVINOLIN; PHENOBARBITAL; PHENYTOIN; PROPRANOLOL; RIFAMPICIN; SUCRALFATE; THIAMAZOLE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CASE REPORT; DRUG ANTAGONISM; ECHOGRAPHY; FEMALE; FOOD DRUG INTERACTION; FREE THYROXINE INDEX; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; MALABSORPTION; PATIENT COMPLIANCE; PRACTICE GUIDELINE; THYROID FUNCTION TEST; THYROID SCINTISCANNING; THYROTROPIN BLOOD LEVEL; TREATMENT FAILURE;

ADULT; FEMALE; HUMANS; HYPOTHYROIDISM; MALABSORPTION SYNDROMES; THYROXINE; TREATMENT REFUSAL;

EID: 4143068032     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Rallison ML, Dobyns BM, Meikle AW, Bishop M, Lyon JL, Stevens W. Natural history of thyroid abnormalities: prevalence, incidence, and regression of thyroid diseases in adolescents and young adults. Am J Med 1991;91:363-70.
2. Smith RN, Taylor SA, Massey JC. Controlled clinical trial of combined triiodothyronine and thyroxine in the treatment of hypothyroidism. BMJ 1970;4:145-8
3. Dong BJ, Hauck WW, Gambertoglio JG, et al. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism. JAMA 1997;277:1205-13.
4. Ain KB, Refetoff S, Fein HG, Weintraub BD. Pseudomalabsorption of levothyroxine. JAMA 1991;266:2118-20.
5. Watts NB, Blevins LS Jr. Endocrinology. JAMA 1994;271:1666-8.
6. 3) using turnover rate technique. J Clin Invest 1973;52:805-11.
7. Bevan JS, Munro JF. Thyroxine malabsorption following intestinal bypass surgery. Int J Obes 1986;10:245-6.
8. Azizi F, Belur R, Albano J. Malabsorption of thyroid hormones after jejunoileal bypass for obesity. Ann Intern Med 1979;90:941-2.
9. Smyrniotis V, Vaos N, Arkadopoulos N, Kostopanagiotou G, Theodoraki K, Lambrou A. Severe hypothyroidism in patients dependent on prolonged thyroxine infusion through a jejunostomy. Clin Nutr 2000;19:65-7.
10. Stone E, Leiter LA, Lambert JR, Silverberg JDH, Jeejeebhoy KN, Burrow GN. L-Thyroxine absorption in patients with short bowel. J Clin Endocrinol Metab 1984;59:139-41.
11. Mandel SJ, Larsen PR, Seely EW, Brent GA. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med 1990;323:91-6.
12. Choe W, Hays MT. Absorption of oral thyroxine. Endocrinologist 1995;5/3:222-8.
13. Bell DSH, Ovalle F. Use of soy protein supplement and resultant need for increased dose of levothyroxine. Endocr Pract 2001;7:193-4.
14. Harmon SM, Seifert CF. Levothyroxine-cholestyramine interaction reemphasized. Ann Intern Med 1991;115:658-9
15. .Witsum JI, Jacobs LS, Schonfeld G. Thyroid hormones and thyrotropin levels in patients placed on colestipol hydrochloride. Ann Intern Med 1978;46:838-40.
16. Sperber AD, Liel Y. Evidence for interference with the intestinal absorption of levothyroxine sodium by aluminum hydroxide. Arch Intern Med 1992;152:183-4.
17. Campbell NR, Hasinoff BB, Stalts H, Rao B, Wong NC. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med 1992;117:1010-3.
18. Leger CS, Ooi TC. Ferrous fumarate-induced malabsorption of thyroxine. Endocrinologist 1999;9:493-5.
19. Havrankova J, Lahaie R. Levothyroxine binding by sucralfate. Ann Intern Med 1992;117:445-6.
20. Lumholtz IB, Siersbaek-Nielsen K, Faber J, Kirkegaard C, Friis T. The effect of propranolol and 3′,3′,5′ -triiodothyronine evaluated by non-compartmental kinetics. J Clin Endocrinol Metab 1978;47:587-9.
21. Mersebach H, Rasmussen AK, Kirkegaard L, Feldt-Rasmussen U. Intestinal adsorption of levothyroxine by antacids and laxatives: case stories and in vitro experiments. Pharmacol Toxicol 1999;84:107-9.
22. Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA 2000;283:2822-5.
23. Csako G, McGriff NJ, Rotman-Pikielny P, Sarlis NJ, Pucino F. Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders. Ann Pharmacother 2001;35:1578-83.
24. Demke DM. Drug interaction between thyroxine and lovastatin [Letter]. N Engl J Med 1989;321:1341-2.
25. Bergman F, Halvorsen P, Linden W van der. Increased excretion of thyroxine by feeding activated charcoal to Syrian hamsters. Acta Endocrinol 1967;56:521-4.
26. Faber J, Lumholtz IB, Kirkegaard C, et al. The effects of phenytoin (diphenylhydantoin) on the extrathyroidal turnover of thyroxine, 3′,5′,3′-triiodothyronine, 3′,3′,5′-triiodothyronine, and 3′,5′ -diiodothyronine in man. J Clin Endocrinol Metab 1985;61:1093-9.
27. De Luca F, Arrigo T, Pandullo E, Siracusano MF, Benvega S, Trimarchi F. Changes in thyroid function tests induced by 2 month carbamazepine treatment in L-thyroxine-substituted hypothyroid children. Eur J Pediatr 1986;145:77-9.
28. Isley WL. Effect of rifampin therapy on thyroid function tests in a hypothyroid patient on replacement L-thyroxine. Ann Intern Med 1987;107:517-8.
29. Figge J, Diuhy RG. Amiodarone-induced elevation of thyroid stimulating hormone in patients receiving levothyroxine for primary hypothyroidism. Ann Intern Med 1990;113:553-5.
30. Geatti O, Barkan A, Turrin D, Orsolon PG, Shapiro B. L-Thyroxine malabsorption due to the injection of herbal remedies. Thyroidol Clin Exp 1993;5:97-102.
31. Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy in patients with thyroid disease. Ann Intern Med 1993;119:492-502.
32. Roti E, Minelli R, Gardini E, Braverman LE. The use and misuse of Thyroid Hormone. Endocr Rev 1993;14:401-23.
33. Hays MT. Localization of human thyroxine absorption. Thyroid 1991;1:241-8.
34. Gattaz WF, Dressing H, Hewer W. Munchhausen syndrome: psychopathology and management. Psychopathology 1990;23:33-9.
35. Payer J, Sladekova K, Kinova S, et al. Autoimmune thyroiditis with severe hypothyroidism resistant to the treatment with high peroral doses of thyroxine: case report. Endocr Regul 2000,34:189-93.
36. Jauk B, Mikosch P, Gallowitsch HJ, et al. Unusual malabsorption of levothyroxine. Thyroid 2000;10:93-5.
37. Ogawa D, Otsuka F, Mimura U, et al. Pseudomalabsorption of levothyroxine: a case report. Endocr J 2000;47:45-50.
38. Karczewaska K, Lukas W, Lukasik M, Kasner J, Dyduch A, Sliwa F. Serum trijodothyroxine and thyroxine levels in children with celiac disease. Polski Tygodnik Lekarski 1992;47:86-8.
39. Rings EHHM, Grand RJ, Buller HA. Lactose intolerance and lactase deficiency in children. Curr Opin Pediatr 1994;6/5:562-7.
40. Mani LS, Desai KB, Joseph LJ, Ganatra RD. Intestinal absorption of labelled triiodothyronine in man. Indian J Gastroenterol 1985;4:239-41.
41. Seppel T, Rose F, Schlaghecke R. Chronic intestinal Giardiasis with isolated levothyroxine malabsorption as reason for severe hypothyroidism - Implications for localization of thyroid hormone absorption in the gut. Exp Clin Endocrinol Diabetes 1996;104:180-2.
42. Hays MT. Absorption of oral thyroxine in man. J Clin Endocrinol Metab 1968;28:749-56.
43. Lehrner LM, Weir MR. Acute ingestions of thyroid hormones. Pediatrics 1984;73:313-7.